COVID-19 Pandemic and Vaccine Resource Library

This body of work clarifies many of the reasons for vaccine hesitancy, including the tempting retreat to the perceived safety of inaction; considers how social movements emerge and succeed and how to build such a movement to broaden vaccine acceptance; and examines the value of activities that foster behavior change to drive vaccine use.

This tracker provides current data on the share of the population having received at least one COVID-19 vaccine dose by country, income-level, region, and globally. Additionally, this tool estimates future vaccine coverage levels if the current rate of first dose administration is maintained going forward and compares these coverage levels to global vaccination targets.

From the BOOST Community: “This podcast will provide insights from the frontlines of COVID-19 vaccine sites around the globe as well as feature experts to answer Boost Community’s questions on COVID-19 vaccines.”

To better understand the impact of the pandemic on childhood routine immunisation, this study estimated disruptions in vaccine coverage associated with the pandemic in 2020, globally and by Global Burden of Disease (GBD) super-region.

This on-demand webinar seeks to demystify the myths and misconceptions around COVID-19 Vaccine

Powering Vaccine R&D: Opportunities for Transformation is a new report published by the Sabin-Aspen Vaccine Science & Policy Group that examines the core components of the vaccine ecosystem and finds opportunities to transform and accelerate the development of vaccines. The report proposes five “Big Ideas” to strengthen efficiency and responsiveness in vaccine R&D.

This document lists tools and resources for misinformation analysis and fact-checking.

In this study, the authors aimed to determine the acceptability of COVID-19 vaccine among persons at high risk of COVID-19 morbidity and mortality in Uganda.

This study answers the questions: what are the social and individual estimates of the social value of a Covid-19 vaccine, and how can we incentivise vaccine uptake?

From the authors: “In this Health Policy paper, we review potential challenges to success in each of these dimensions and discuss policy implications. To guide our review, we developed a dashboard to highlight key characteristics of 26 leading vaccine candidates, including efficacy levels, dosing regimens, storage requirements, prices, production capacities in 2021, and stocks reserved for low-income and middle-income countries. We use a traffic-light system to signal the potential contributions of each candidate to achieving global vaccine immunity, highlighting important trade-offs that policy makers need to consider when developing and implementing vaccination programmes.”